鋅業股份(000751.SZ):於洪之子於躍將成為實控人
格隆匯11月26日丨鋅業股份(000751.SZ)公佈,近日,公司接到控股股東中冶葫蘆島有色金屬集團有限公司(簡稱“中冶有色”)的通知,公司實際控制人於洪及其一致行動人林桂娟擬於2021年11月與於躍簽訂《葫蘆島宏躍集團有限公司股權轉讓協議》,於洪將其持有的葫蘆島宏躍集團有限公司(簡稱“宏躍集團”)36%股權及林桂娟將其持有的宏躍集團16%股權一併轉讓給於躍,於躍將持有宏躍集團68%的股權,該股權轉讓事項尚未辦理工商變更手續。
於躍為於洪之子。該次股權調整完成後,於躍將成為公司的實際控制人,其一致行動人為於朝旭、於航,宏躍集團仍為中冶有色的第一大股東,中冶有色與公司股權控制關係未發生變化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.